Last updated: September 11, 2023

Summarytoggle arrow icon

Hyperkalemia (high serum potassium) is a common and potentially life-threatening disorder of potassium balance. The most common cause is decreased kidney function. It can also be caused by acidosis, cell breakdown, endocrinological disturbances (e.g., hypoaldosteronism, hypocortisolism), and drugs such as potassium-sparing diuretics, angiotensin-converting enzyme (ACE) inhibitors, nonsteroidal antiinflammatory drugs (NSAIDs), and digoxin. Serum potassium (K+) is often falsely elevated due to the method of sampling and levels should be confirmed with repeat testing. To determine the underlying cause of hyperkalemia, it is essential to review the patient's medications, check kidney and endocrine function, and screen for cell lysis (e.g., hemolysis, rhabdomyolysis) and acid-base disorders. Acute increases in serum K+ are very dangerous, as they influence the resting membrane potential and thus the electrical excitability of cells. These changes can lead to life-threatening cardiac arrhythmias. It is, therefore, essential to obtain an ECG to determine the level of cardiotoxicity. Management depends on the severity of the hyperkalemia and includes restriction of dietary K+, as well as medications to bind, shift, or eliminate K+, or to stabilize the cardiac membrane (e.g., calcium gluconate) if necessary. In refractory cases, dialysis may be required. Serum K+ should be monitored closely until it is corrected.

See also “Hypokalemia.”

Definitiontoggle arrow icon

  • Hyperkalemia: Serum potassium level > 5 mEq/L
  • Acute hyperkalemia: Abnormal ↑ K+ not known to be chronic
  • Chronic hyperkalemia: Recurrent episodic ↑ K+ that require ongoing treatment

References: [1][2]

Etiologytoggle arrow icon

Errors in blood-drawing technique may lead to red blood cell lysis and a falsely elevated serum potassium concentration (pseudohyperkalemia)!

When K+ shifts out of the cell, it's a BAD LOSS! – Beta blockers, Acidosis, Digoxin, Lysis, hyperOsmolality, high Sugar, Succinylcholine


Pathophysiologytoggle arrow icon

  • Potassium is an important factor in maintaining the resting membrane potential
  • ↑ Extracellular K+concentration → resting membrane potential becomes less negative than -90 mV → ↑ excitability

Particularly acute extracellular changes in concentration influence excitability! Chronic changes lead to intracellular compensation!

Clinical featurestoggle arrow icon

Symptoms usually occur if serum potassium levels are > 7.0 mEq/L or they change rapidly.

Hyperkalemia (and hypokalemia) can cause cardiac arrhythmia and lead to ventricular fibrillation!References:[1][7][8][9]

Diagnosticstoggle arrow icon

Approach [10]

Laboratory studies [11][12]

An inverse relationship between serum K+ and pH (e.g., pH → ↑ K+) has previously been observed in specific types of metabolic acidosis. However, the underlying mechanisms are complex and this association is inconsistent in clinical practice. [11][15]

ECG findings in hyperkalemia [16][17][18]

There is a weak correlation between serum K+ levels and the severity of ECG changes. Findings are more likely to occur with rapid-onset hyperkalemia.

  • Mild hyperkalemia: 5.5–6.4 mEq/L
  • Moderate hyperkalemia: 6.5–8.0 mEq/L
    • Lengthening of QRS interval (QRS complex widening)
    • Widening and flattening of P wave, which eventually disappears
  • Severe hyperkalemia: > 8.0 mEq/L

Investigation of underlying causes [19][20][21]

Depending on symptoms and risk factors, further testing may be appropriate, particularly if renal function is normal.

Review the patient's medical history and medication list to help identify potential causes of hyperkalemia. [19]

Treatmenttoggle arrow icon

Therapeutic approach to hyperkalemia [2][11][19][23]

  • Determine severity: See “Risk stratification.”
  • Hyperkalemic emergency: Patients require immediate management.
    • Start continuous cardiac monitoring.
    • If there are ECG changes: Stabilize the cardiac membrane first, e.g., with IV calcium gluconate.
    • Initiate treatment to shift potassium intracellularly, e.g.:
    • Consider nephrology and critical care consults.
    • Admit to hospital for ongoing monitoring and treatment.
    • Repeat serum K+ at minimum 1, 2, 4, 6, and 24 hours after treatment.
  • All patients
    • Identify and treat underlying causes.
    • Review medications and discontinue or modify dosing of medications that may be contributing to hyperkalemia.
      • Decrease dose (or consider discontinuation) of drugs required to treat underlying conditions, e.g., RAAS inhibitors.
      • Avoid nonessential drugs associated with hyperkalemia (e.g., NSAIDs, over-the-counter supplements such as milkweed).
    • Start a low potassium diet and avoid salt substitutes (consider nutrition consult). [12][24]
    • Consider treatment to remove potassium from the body, e.g., cation-exchange resins, diuretics, hemodialysis.
    • Repeat potassium regularly until it is within normal range, e.g., within 1–3 days. [25]

Urgent K+-lowering treatment may be necessary even in the absence of ECG changes.

To remember K+-lowering treatments, think C BIG K Die (if you see a big serum K+, your patient may die!): Calcium salts, Beta-agonists/Bicarbonate, Insulin + Glucose, Kation exchange medication, Dialysis/Diuretics.

The effects of calcium salts, insulin/glucose, and inhaled SABAs on serum K+ are temporary. Repeat doses may be required while waiting for interventions to remove K+ from the body to take effect.

Risk stratification [26]

  • Hyperkalemic emergency is an acute severe elevation that requires urgent lowering and occurs if any of the following are present:
  • Less urgent hyperkalemia (typically chronic elevations that can be lowered more slowly)
    • Patient is asymptomatic
    • Serum K+ is 5.5–6.0 mEq/L
    • Patient has no high-risk comorbidities

Cardiac arrhythmias due to hyperkalemia can cause sudden death.

Cardiac membrane stabilization [23]

Calcium salts reduce cardiac irritability.

Calcium salts should result in normalization of the ECG appearance within 5 minutes; observe the cardiac monitor following initial treatment and repeat the dose if the ECG tracing still appears abnormal.

Calcium salts have no influence on serum K+ levels and therefore should be paired with a K+-lowering agent.

Intracellular potassium shifting [11][26][28]

These drugs should be given in tandem with calcium salts (if calcium is indicated).

Avoid administering calcium carbonate and sodium chloride through the same IV line without extensive flushing in between because of the risk of calcium precipitation. [30]

Enhanced potassium elimination [2][23][28]

  • Not required for all patients; treatment of the underlying cause may be sufficient.
  • The choice of treatment depends on underlying medical conditions and volume status.

Cation-exchange medications [26][31]

  • Mechanism of action: These drugs release Na+ or Ca2+ ions in the gut, which are exchanged for K+, thereby enhancing enteral K+ elimination.
  • Clinical applications: nonurgent lowering of K+ [11]
  • Options
  • Adverse effects
  • Considerations
    • Avoid simultaneous administration with other oral medications, as resins may bind them, reducing absorption.
    • Give with a laxative (avoid sorbitol). [33]

Sodium polystyrene sulfonate carries a risk of intestinal necrosis (especially if combined with the laxative sorbitol) and should be avoided in patients with abnormal bowel function. [33]


  • Most effective definitive therapy for refractory hyperkalemia
  • Preferred option in patients with end-stage renal failure ; (particularly if already receiving renal replacement therapy), or oliguria.
  • For all other patients, avoided as a first-line option because of its invasive nature and adverse effects

Loop diuretics [28]

Acute management checklisttoggle arrow icon

All patients

  • Determine the severity of hyperkalemia.
  • Identify and treat underlying causes.
  • Review medications and discontinue or adjust dosing of medications that may be contributing to hyperkalemia.
  • Consider starting medication to enhance K+ elimination, e.g., cation-exchange medication, diuretics for patients with volume overload.
  • Repeat K+ levels to assess response to treatment.
  • Start a low K+ diet.
  • Consult nephrology for patients with ESRD or refractory hyperkalemia, e.g., for consideration of hemodialysis.

Patients with hyperkalemic emergency

Referencestoggle arrow icon

  1. Lederer E. Hyperkalemia. In: Batuman V, Hyperkalemia. New York, NY: WebMD. Updated: January 11, 2016. Accessed: February 9, 2017.
  2. Palmer BF, Carrero JJ, Clegg DJ, et al. Clinical Management of Hyperkalemia. Mayo Clinic Proceedings. 2020.doi: 10.1016/j.mayocp.2020.06.014 . | Open in Read by QxMD
  3. Mount DB. Causes and evaluation of hyperkalemia in adults. In: Post TW, ed. UpToDate. Waltham, MA: UpToDate. Last updated: October 15, 2014. Accessed: February 9, 2017.
  4. Velázquez H, Perazella MA, Wright FS, Ellison DH. Renal mechanism of trimethoprim-induced hyperkalemia. Ann Intern Med. 1993; 119 (4): p.296-301.
  5. Aronson PS, Giebisch G. Effects of pH on Potassium: New Explanations for Old Observations. Journal of the American Society of Nephrology. 2011; 22 (11): p.1981-1989.doi: 10.1681/asn.2011040414 . | Open in Read by QxMD
  6. Digoxin toxicity. Updated: February 9, 2017. Accessed: February 9, 2017.
  7. Agabegi SS, Agabegi ED. Step-Up To Medicine. Lippincott Williams & Wilkins ; 2013
  8. Mount DB. Clinical manifestations of hyperkalemia in adults. In: Post TW, ed. UpToDate. Waltham, MA: UpToDate. Last updated: September 24, 2015. Accessed: February 9, 2017.
  9. Hyperkalemia. Updated: January 1, 2008. Accessed: February 9, 2017.
  10. Lindner G, Burdmann EA, Clase CM, et al. Acute hyperkalemia in the emergency department: a summary from a Kidney Disease: Improving Global Outcomes conference. Eur J Emerg Med. 2020; 27 (5): p.329-337.doi: 10.1097/mej.0000000000000691 . | Open in Read by QxMD
  11. Evans KJ, Greenberg A. Hyperkalemia: a review. J Intensive Care Med. 2005; 20 (5): p.272-90.doi: 10.1177/0885066605278969 . | Open in Read by QxMD
  12. Palmer BF. A physiologic-based approach to the evaluation of a patient with hyperkalemia. Am J Kidney Dis. 2010; 56 (2): p.387-93.doi: 10.1053/j.ajkd.2010.01.020 . | Open in Read by QxMD
  13. Palmer BF, Clegg DJ. Hyperkalemia. JAMA. 2015; 314 (22): p.2405-6.doi: 10.1001/jama.2015.9230 . | Open in Read by QxMD
  14. Sevastos N, Theodossiades G, Archimandritis AJ. Pseudohyperkalemia in Serum: A New Insight into an Old Phenomenon. Clin Med Res. 2008; 6 (1): p.30-32.doi: 10.3121/cmr.2008.739 . | Open in Read by QxMD
  15. Lee Hamm L, Hering-Smith KS, Nakhoul NL. Acid-Base and Potassium Homeostasis. Semin Nephrol. 2013; 33 (3): p.257-264.doi: 10.1016/j.semnephrol.2013.04.006 . | Open in Read by QxMD
  16. Montague BT, Ouellette JR, Buller GK. Retrospective review of the frequency of ECG changes in hyperkalemia. Clin J Am Soc Nephrol. 2008; 3 (2): p.324-30.doi: 10.2215/CJN.04611007 . | Open in Read by QxMD
  17. Mattu A, Brady WJ, Robinson DA. Electrocardiographic manifestations of hyperkalemia. Am J Emerg Med. 2000; 18 (6): p.721-9.doi: 10.1053/ajem.2000.7344 . | Open in Read by QxMD
  18. Herndon S, Holland B, Vinayak A. What is the role and impact of the ECG in the patient with hyperkalemia?. In: Brady WJ, Truwit JD, eds.$Critical Decisions in Emergency and Acute Care Electrocardiography. 9, ed. Wiley-Blackwell; 2009.
  19. Viera AJ, Wouk N. Potassium disorders: Hypokalemia and hyperkalemia. Am Fam Physician. 2015; 92 (6): p.487-495.
  20. Lehnhardt A, Kemper MJ. Pathogenesis, diagnosis and management of hyperkalemia. Pediatr Nephrol. 2010; 26 (3): p.377-384.doi: 10.1007/s00467-010-1699-3 . | Open in Read by QxMD
  21. Eleftheriadis T, Leivaditis K, Antoniadi G, Liakopoulos V. Differential diagnosis of hyperkalemia: an update to a complex problem.. Hippokratia. 2012; 16 (4): p.294-302.
  22. Kamel KS, Halperin ML. Intrarenal urea recycling leads to a higher rate of renal excretion of potassium. Curr Opin Nephrol Hypertens. 2011; 20 (5): p.547-554.doi: 10.1097/mnh.0b013e328349b8f9 . | Open in Read by QxMD
  23. Parham WA, Mehdirad AA, Biermann KM, Fredman CS. Hyperkalemia revisited.. Tex Heart Inst J. 2006; 33 (1): p.40-7.
  24. Lanham-New SA, Lambert H, Frassetto L. Potassium. Advances in Nutrition. 2012; 3 (6): p.820-821.doi: 10.3945/an.112.003012 . | Open in Read by QxMD
  25. Clinical Practice Guidelines: Treatment of Acute Hyperkalaemia in Adults. Updated: June 1, 2020. Accessed: December 13, 2021.
  26. Weisberg LS. Management of severe hyperkalemia. Crit Care Med. 2008; 36 (12): p.3246-51.doi: 10.1097/CCM.0b013e31818f222b . | Open in Read by QxMD
  27. Medford-Davis L, Rafique Z. Derangements of Potassium. Emerg Med Clin North Am. 2014; 32 (2): p.329-347.doi: 10.1016/j.emc.2013.12.005 . | Open in Read by QxMD
  28. Dépret F, Peacock WF, Liu KD, Rafique Z, Rossignol P, Legrand M. Management of hyperkalemia in the acutely ill patient. Annals of Intensive Care. 2019; 9 (1).doi: 10.1186/s13613-019-0509-8 . | Open in Read by QxMD
  29. Jameson JL, Fauci AS, Kasper DL, Hauser SL, Longo DL, Loscalzo J. Harrison's Principles of Internal Medicine, Twentieth Edition (Vol.1 & Vol.2). McGraw-Hill Education / Medical ; 2018
  30. Adeva-Andany MM, Fernández-Fernández C, Mouriño-Bayolo D, Castro-Quintela E, Domínguez-Montero A. Sodium Bicarbonate Therapy in Patients with Metabolic Acidosis. Scientific World Journal. 2014; 2014: p.1-13.doi: 10.1155/2014/627673 . | Open in Read by QxMD
  31. Packham DK, Rasmussen HS, Lavin PT, et al. Sodium Zirconium Cyclosilicate in Hyperkalemia. N Engl J Med. 2015; 372 (3): p.222-231.doi: 10.1056/nejmoa1411487 . | Open in Read by QxMD
  32. Ingelfinger JR. A New Era for the Treatment of Hyperkalemia?. N Engl J Med. 2015; 372 (3): p.275-277.doi: 10.1056/nejme1414112 . | Open in Read by QxMD
  33. Kamel KS, Schreiber M. Asking the question again: are cation exchange resins effective for the treatment of hyperkalemia?. Nephrol Dial Transplant. 2012; 27 (12): p.4294-4297.doi: 10.1093/ndt/gfs293 . | Open in Read by QxMD
  34. Lederer E. Hypokalemia. In: Batuman V, Hypokalemia. New York, NY: WebMD. Updated: December 29, 2016. Accessed: February 9, 2017.
  35. Mount DB. Causes of hypokalemia in adults. In: Post TW, ed. UpToDate. Waltham, MA: UpToDate. Last updated: January 5, 2016. Accessed: February 9, 2017.
  36. Chrousos GP. Glucocorticoid Therapy and Cushing Syndrome. In: Kemp S, Glucocorticoid Therapy and Cushing Syndrome. New York, NY: WebMD. Updated: December 11, 2015. Accessed: February 9, 2017.
  37. Yu ASL. Causes of hypomagnesemia. In: Post TW, ed. UpToDate. Waltham, MA: UpToDate. Last updated: February 4, 2016. Accessed: February 9, 2017.
  38. Mount DB. Clinical manifestations and treatment of hypokalemia in adults. In: Post TW, ed. UpToDate. Waltham, MA: UpToDate. Last updated: January 7, 2016. Accessed: February 9, 2017.
  39. Potassium and Your CKD Diet. Updated: February 9, 2017. Accessed: February 9, 2017.
  40. Hannibal GB. Severe Hyperkalemia With Sine Wave ECG Pattern. AACN Adv Crit Care. 2015; 26 (2): p.177-80.doi: 10.1097/NCI.0000000000000073 . | Open in Read by QxMD
  41. Montford JR, Linas S. How Dangerous Is Hyperkalemia?. J Am Soc Nephrol. 2017; 28 (11): p.3155-3165.doi: 10.1681/ASN.2016121344 . | Open in Read by QxMD
  42. Kovesdy CP. Updates in hyperkalemia: Outcomes and therapeutic strategies. Rev Endocr Metab Disord. 2017; 18 (1): p.41-47.doi: 10.1007/s11154-016-9384-x . | Open in Read by QxMD

Icon of a lock3 free articles remaining

You have 3 free member-only articles left this month. Sign up and get unlimited access.
 Evidence-based content, created and peer-reviewed by physicians. Read the disclaimer